Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

@article{Rimensberger2001InhaledNO,
  title={Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.},
  author={Peter C. Rimensberger and Isabelle Spahr-Schopfer and Michel Berner and Edgar Jaeggi and Afksendiyos Kalangos and Beat Friedli and Maurice Beghetti},
  journal={Circulation},
  year={2001},
  volume={103 4},
  pages={
          544-8
        }
}
BACKGROUND Inhaled nitric oxide (iNO) has been used to assess the vasodilator capacity of the pulmonary vascular bed in children with congenital heart disease and elevated pulmonary vascular resistance. Inhaled iloprost is a pulmonary vasodilator for the long-term treatment of pulmonary hypertension (PHT). Because these 2 vasodilators act through different pathways (release of cGMP or cAMP, respectively), we compared the pulmonary vasodilator capacity of each. METHODS AND RESULTS A total of… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 76 CITATIONS, ESTIMATED 45% COVERAGE

Combined effect of aerosolized iloprost and oxygen on assessment of pulmonary vasoreactivity in children with pulmonary hypertension.

  • Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2001
2018

CITATION STATISTICS

  • 6 Highly Influenced Citations

  • Averaged 1 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES